May 2, 2024, 12:00 AM
May 1, 2024, 7:02 AM
Novo Nordisk owner invests millions in quantum computing
Euro News
/
Source
Novo Holdings, the parent company of the maker of weight-loss drugs Ozempic and Wegovy, is investing millions to create a global innovation hub for quantum technology in Denmark.
Yahoo! News
/
Source
Danish obesity drugmaker Novo Nordisk to invest $200 million in quantum computing startups. Experts believe quantum computing may prove to be among the most transformational technological developments of the 21st century. Novo Holdings has 77% of voting shares in Danish drug maker Novo.
Opinions
You've reached the end